GHR Mulhouse Sud-Alsace

Mulhouse 68100

0 studies enrolling now · 5 studies all time

What they study most

IGF1 Deficiency, Leukemia, Myelomonocytic, Chronic, Lupus Erythematosus, Systemic, Myelodysplastic Syndromes, Sickle Cell Disease

Studies at this site

• Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD). — Recruiting now
• A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) — Running, not enrolling
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed
• Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed